Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.30 |
| ▸ | PKM | P14618 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.30 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18775925 | 0.93 | KMT2A (0.33) | KMT2APKMALDH1A1L3MBTL1MEN1 | |
| SCHEMBL10172800 | 0.90 | APP (0.31) | — | |
| SCHEMBL10172843 | 0.88 | APP (0.31) | — | |
| SCHEMBL10067085 | 0.85 | ALDH1A1 (0.39) | KMT2AALDH1A1HTTSMN1; SMN2L3MBTL1 | |
| SCHEMBL18775801 | 0.85 | SMN1; SMN2 (0.37) | KMT2AALDH1A1HTTRAB9ASMN1; SMN2 | |
| SCHEMBL18775805 | 0.84 | ALDH1A1 (0.41) | KMT2AALDH1A1SMN1; SMN2L3MBTL1MEN1 | |
| SCHEMBL18775811 | 0.84 | ALDH1A1 (0.41) | KMT2AALDH1A1SMN1; SMN2L3MBTL1MEN1 | |
| SCHEMBL18775804 | 0.84 | ALDH1A1 (0.41) | KMT2AALDH1A1SMN1; SMN2L3MBTL1MEN1 | |
| SCHEMBL18776003 | 0.84 | ALDH1A1 (0.41) | KMT2AALDH1A1SMN1; SMN2L3MBTL1MEN1 | |
| SCHEMBL18775803 | 0.84 | ALDH1A1 (0.41) | KMT2AALDH1A1SMN1; SMN2L3MBTL1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3168207-A1 | MONOMER, POLYMER, RESIST COMPOSITION, AND PATTERNING PROCESS | Shin-Etsu Chemical Co., Ltd. (JP) | 2017-05-17 | — | — | EP | disclosed |
| US-9200098-B2 | Radiation-sensitive composition and compound | JSR CORPORATION (JP) | 2015-12-01 | — | — | US | disclosed |
| US-9200098-B2 | Radiation-sensitive composition and compound | JSR CORPORATION (JP) | 2015-12-01 | — | — | US | disclosed |
| US-20120164582-A1 | RADIATION-SENSITIVE COMPOSITION AND COMPOUND | JSR CORPORATION (JP) | 2012-06-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120164582-A1 | RADIATION-SENSITIVE COMPOSITION AND COMPOUND | RAD51, RER1, ATP6AP1 | KMT2A 2301/4885PKM 1371/4885ALDH1A1 1300/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.